30 minutes can save your life...skin checks

[Trajan]

smegma

 

[strollingbones]

great this was an informative post that would be read in the flame zone...but since it got moved here it will simply die....

why i ask.....must you move things to these mallie subforums that no one is gonna read

 

[Katzndogz]

The sun is bad, it causes cancer and obama should ban it.

 

[Dabs]

The sun is bad, it causes cancer and obama should ban it.

The sun isn't the only thing that causes cancer.

 

[strollingbones]

i would like to thank the mod who had to move this for no reason....now its a dead thread instead of informing people of skin cancer...thank you for doing your job....which didnt help posters....but i want to thank you for making sure it died a slow death in this forum.....


thanks again

 

[strollingbones]

i wont even bother with rocky mountain spotted fever......since it will just be put away to die

 

[MeBelle]

Great thread Bonez!

I am a melanoma survivor.

 

[strollingbones]

omgosh....where and how much did they remove? how did you find it....you are so lucky.....

 

[MeBelle]

It was on my leg, they removed about a 50cent piece size.

I just 'knew' it wasn't right.

I have to get chest xrays every year.

So far, so good!

Bless your heart Bonez!

 

[Sunshine]

i wont even bother with rocky mountain spotted fever......since it will just be put away to die

Around here, we have more Lyme disease than spotted fever. A few years back we ha a case of tetanus in a woman who didn't keep here DT shots up. We have become too casual about things that our parents knew were deadly. Because we don't see it any longer, we think it is gone, but some things well never be gone. Everyone needs to get into a 'rhythm' on their shots. I do mine on the '5' and '10' years.

 

[strollingbones]

that is all they removed? most of the time they go deep and wide......

how long ago was this?

 

[strollingbones]

i wont even bother with rocky mountain spotted fever......since it will just be put away to die

Around here, we have more Lyme disease than spotted fever. A few years back we ha a case of tetanus in a woman who didn't keep here DT shots up.l

i dont know much about lyme....i know about rocky mountain spotted fever....and the tricky symptoms...

 

[MeBelle]

It was fairly small, so they did go wide and I have about an a half inch indent where it was.

very sexxxxyyyyy!

Fifteen years ago.

 

[strollingbones]

15 yrs? that is survivor territory for sure

 

[strollingbones]

It was fairly small, so they did go wide and I have about an a half inch indent where it was.

very sexxxxyyyyy!

Fifteen years ago.

dying of skin cancer is not sexy i assure you.....

and it hits the young......children need to be check too

 

[strollingbones]

no one should die of skin cancer...that is my point.....regular self checks...watch for moles that are just weird....(now a friend of mine has a mole that people come up to her and tell her to get checked...she has and its nothing) watch for bleeding...moles should not bleed....

use sunscreen and cover...no tanning beds...spray only

 

[Sunshine]

15 yrs? that is survivor territory for sure

Only if it is still localized. When I worked that oncology floor I learned that once it is in a lymph node it is no longer localized. A lymph node! Then it has metastasized. The lymphatic system filters fluid in the body, so even though you may only find it in one node, cells have already been scattered and planted.

 

[strollingbones]

am survived two bouts of the lesser hodgkin's lymphoma .....she was declared a survivor after 10 years...and yes she still goes for x rays

 

[waltky]

Melanoma research shows promising treatments...

Research shows promising treatments against skin cancer
4 June`12 - Two new experimental treatments against advanced melanoma have shown promise in keeping the deadly skin cancer at bay, according to research presented in the United States on Monday.

The agents, known as Dabrafenib and Trametinib, are being developed by the British pharmaceutical firm GlaxoSmithKline, and were tested in clinical trials against standard chemotherapy treatments. The trial on Trametinib included 322 people, of whom 214 took the experimental drug while the rest did standard chemotherapy, researchers said at the American Society of Clinical Oncology meeting in Chicago. More than 22 percent of those on Trametinib responded to treatment compared to eight percent in the chemo group. The Trametinib group also experienced a median 4.8 month period in which the cancer did not advance, and saw their risk of dying from skin cancer diminish by 46 percent compared to the chemo group -- 81 percent were still alive after six months of treatment compared to 67 percent in the control group.

The phase III trial was the first to evaluate a treatment against melanoma that inhibits a protein known as MEK, and may help about half of all melanoma patients who have a mutation in the BRAF gene that fuels tumor growth. "This is the first in a new class of targeted drugs that could benefit patients with melanoma who have BRAF mutations," said Caroline Robert, head of Dermatology at the Institute Gustave Roussy in Paris, France. "The findings show that targeting the MEK molecular pathway is a viable strategy for treating many people with the disease," Robert added. "Trametinib is likely to become another first-line treatment option for patients with advanced melanoma."

One other therapy on the market, vemurafenib (Zelboraf), is currently approved in the United States and Europe for advanced melanoma. The second trial involved Dabrafenib, which also targets cancers with the BRAF mutation, and showed a 70 percent lower risk of cancer progression compared to those treated with chemotherapy alone (5.1 months versus 2.7 months. The phase III trial included 250 participants who had not been treated with any drug prior to enrollment and who had been diagnosed with inoperable melanoma, 187 of whom took the experimental drug while the rest were given standard chemotherapy. Half of patients in the Dabrafenib group responded to therapy, compared to six percent of patients treated with a chemotherapy treatment known as dacarbazine.

The median time in which the cancer did not progress was 5.1 months in the Dabrafenib group compared to 2.7 months in the control group. More study is needed to determine the overall survival rate, researchers said. "These findings represent another advance for melanoma and form the foundation for further studies to evaluate the role of Dabrafenib in combination with other drugs," said lead investigator Axel Hauschild, a professor of dermatology at University of Kiel in Germany. According to the US National Cancer Institute, there are about 76,000 new cases of melanoma diagnosed each year in the United States and more than 9,100 deaths.

Source